Camurus Overview

  • Founded
  • 1991
Founded
  • Status
  • Public
  • Employees
  • 134
Employees
  • Stock Symbol
  • CAMX
Stock Symbol
  • Share Price
  • $25.22
  • (As of Friday Closing)

Camurus General Information

Description

Camurus AB is a research and development focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The company's product pipeline includes CAM2038, CAM2029, CAM2032 and others. The company's geographical segments include Europe (of which Sweden), the United States, Japan, Australia, and Other geographical areas.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
STO
Primary Office
  • Ideon Science Park
  • SE-223 70
  • Lund
  • Sweden
+46 046-286 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Camurus Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$25.22 $26.26 $5.88 - $28.42 $1.37B 54.2M 121K -$0.36

Camurus Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 1,130,406 449,717 261,337 568,976
Revenue 28,032 11,165 5,668 6,354
EBITDA (21,441) (37,111) (32,498) (28,015)
Net Income (18,338) (30,646) (26,971) (22,298)
Total Assets 110,310 82,575 40,576 58,135
Total Debt 2,647 2,923 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Camurus Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Camurus‘s full profile, request access.

Request a free trial

Camurus Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Camurus AB is a research and development focused pharmaceutical company. It develops pharmaceuticals for the treatment o
Drug Discovery
Lund, Sweden
134 As of 2020
000.00
0000 0000-00-00
00000000 000.00

00000

pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit
000000000000000
Uppsala, Sweden
000 As of 0000
000.00
0000 0000-00-00
00000000 000.00

00000 00

m, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irur
0000 000000000
Mumbai, India
00000 As of 0000
00000
0.000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Camurus Competitors (26)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Orexo Formerly VC-backed Uppsala, Sweden 000 000.00 00000000 000.00
00000 000000000000 Formerly PE-Backed Mumbai, India 00000 00000 00000000 00000
0000000000 0000000 Corporation Ingelheim am Rhein, Germany 00000
000000-0000000 000 Corporation Karachi, Pakistan 0000
0000000 Corporate Backed or Acquired Raritan, NJ 00000 000000&0
You’re viewing 5 of 26 competitors. Get the full list »

Camurus Executive Team (4)

Name Title Board Seat Contact Info
Fredrik Tiberg Ph.D Chief Executive Officer, Head of Research & President
Eva Pinotti-Lindqvist Chief Financial Officer
Fredrik Joabsson Chief Business Development Officer
Richard Jameson Chief Commercial Officer
To view Camurus’s complete executive team members history, request access »

Camurus Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Camurus Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Camurus‘s full profile, request access.

Request a free trial